Live Breaking News & Updates on Inflarx stops development of vilobelimab

Stay updated with breaking news from Inflarx stops development of vilobelimab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

InflaRx N : 11-2023-InflaRx Reports Third Quarter 2023 Financial Results and Provides Business Update -November 01, 2023 at 09:13 am EDT

Jena, Germany, November 1, 2023 - InflaRx N.V. , a biotechnology company pioneering anti-inflammatory therapeutics targeting the complement system, announced today financial results...

United-states , Germany , German , Thomas-taapken , German-ministry-of-education , Development-expenses , Development-of-vilobelimab , Drug-administration , European-medicines-agency , Inflarx-stops-development-of-vilobelimab , European-union , German-ministry-of-health

InflaRx Reports Third Quarter 2023 Financial Results and Provides Business Update

InflaRx Reports Third Quarter 2023 Financial Results and Provides Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Germany , United-states , Munich , Bayern , German , Nielsc-riedemann , Laurie-doyle , Regina-lutz , Thomas-taapken , Katja-arnold , Drug-administration , Inflarx-pharmaceuticals-inc

InflaRx Reports Third Quarter 2023 Financial Results and Provides Business Update

Single ascending dose (SAD) Phase I data confirm best-in-class potential of orally available C5aR inhibitor INF904; multiple ascending dose (MAD) ...

Germany , United-states , Munich , Bayern , German , Thomas-taapken , Nielsc-riedemann , Regina-lutz , Laurie-doyle , Katja-arnold , Inflarx-stops-development-of-vilobelimab , Inflarx-pharmaceuticals-inc